Hailey‐Hailey disease (HHD) is an autosomal dominant genetic disease caused by a
mutation of the ATP2C1 gene. Corticosteroids, antibiotics or cyclosporine have been …

Apremilast, a small molecule that acts by inhibition of the phosphodiesterase‐4 enzyme, has
been approved by the US Food and Drug Administration for the management of psoriatic …

Hailey–Hailey disease (HHD) is a rare genetic dermatosis characterized by recurrent flaccid
vesicles and blisters on erythematous skin in friction areas. The disease follows a chronic …

Hailey–Hailey disease (HHD) is a rare autosomal-dominant blistering disorder
characterized by recurrent vesicular and erosive lesions at intertriginous sites. We described …

Hailey–Hailey disease (HHD), is an autosomal dominant genodermatosis with a chronic and
refractory clinical course that greatly affects patient quality of life (QoL). Recently, the …

Hailey-Hailey disease (HHD) is a rare autosomal dominant acantholytic dermatosis clinically
characterized by recurrent erythematous plaques and erosions mainly on the intertriginous …

Zusammenfassung Hintergrund Chronisch inflammatorische Hauterkrankungen haben
einen hohen gesellschaftlichen und medizinischen Stellenwert und bedürfen einer …

Background Apremilast is a phosphodiesterase-4 (PDE-4) inhibitor approved by the US-
Food and Drug Administration (US-FDA) for the management of adult patients with plaque …

Darier disease (DD) and Hailey–Hailey disease (HHD) are autosomal dominant disorders
characterized by epidermal acantholysis. They have a similar molecular pathogenesis, with …

Letter to the Editor of HHD. The patient's laboratory investigations did not reveal any notable
abnormalities. Considering the patient's extensive use of medications in the past, which had …